Agents structurally similar to the opioids and probably occupying the same receptor sites in the central nervous system (CNS). In sufficient doses, they block the effects of opiate drugs by competing for the opioid receptor sites. If given after opiate dependence has developed, these agents will precipitate an acute abstinence syndrome.